Title of article
Hepatocellular carcinoma
Author/Authors
Daniel W. Schafer، نويسنده , , Michael F. Sorrell، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 1999
Pages
5
From page
1253
To page
1257
Abstract
Hepatocellular carcinoma (HCC) for most patients is a terminal complication of chronic inflammatory and fibrotic liver disease. With regrettably few exceptions, treatment is largely palliative, and long-term survival is rare. However, the major causes of HCC worldwide are known and preventable. Hepatitis B and C exist only in man; the viruses have no known non-human reservoirs. Transmission of the viruses can be interrupted by vaccination against hepatitis B virus infection and improvements in medical techniques for hepatitis C, for which no vaccine has yet been developed.
Journal title
The Lancet
Serial Year
1999
Journal title
The Lancet
Record number
580094
Link To Document